Ob.Gyn. NewsCapivasertib/fulvestrant improves progression free survival in breast cancerDecember 14, 2022Breast Cancer
Ob.Gyn. NewsGene signature may spare some breast cancer patients from radiationDecember 14, 2022Breast Cancer
Ob.Gyn. NewsEndometrial receptivity testing before IVF seen as unnecessaryDecember 13, 2022Reproductive EndocrinologyBusiness of Medicine
Ob.Gyn. NewsCardiologist sues hospital, claims he was fired in retaliationDecember 13, 2022Business of MedicinePractice Management
Ob.Gyn. NewsImmune dysregulation may drive long-term postpartum depressionDecember 12, 2022Reproductive Endocrinology
Ob.Gyn. NewsBreaking bad news during IVF: How to soften the blowDecember 12, 2022Business of MedicineObstetrics
Ob.Gyn. NewsHigh response rates with T-DXd in early HER2-low breast cancerDecember 12, 2022Breast Cancer
Ob.Gyn. NewsMore states to consider extending postpartum Medicaid coverage beyond 2 monthsDecember 9, 2022Business of Medicine
Ob.Gyn. NewsNo, you can’t see a different doctor: We need zero tolerance of patient biasDecember 9, 2022Business of MedicinePractice Management
Ob.Gyn. NewsStates cracking down harder on docs who sexually abuse patientsDecember 9, 2022Business of MedicinePractice Management
Ob.Gyn. NewsPostpartum hemorrhage rates and risk factors risingDecember 9, 2022HysterectomyObstetrics
Ob.Gyn. NewsOral SERD camizestrant prolongs PFS vs. fulvestrant in breast cancerDecember 9, 2022Breast Cancer
Ob.Gyn. NewsPotential cause of worse outcomes among Black breast cancer patients foundDecember 9, 2022Breast Cancer
